Latest news
Latest news
Manager trims spreads on CLO’s investment grade tranches in partial refinancing
New hire spent spent more than a decade at Arnold & Porter
Deal priced 1bp wide of Oaktree's previous new issue transaction
More articles
More articles
-
Crédit Agricole could expand its synthetic securitization programme to cover more asset classes, after closing a deal to move €1bn of European corporate loans off its balance sheet. -
Valeant Pharmaceuticals, the largest obligor across US CLOs, announced a loss for the second quarter on Tuesday, but its CEO reassured investors and lenders that the plan for a turnaround is still on track.
-
Crédit Agricole is selling €47.5m of second loss synthetic ABS notes, to achieve balance sheet relief on a €1bn portfolio of European corporate loans.
-
The US CLO market is reaping the benefits of newly enriched investors hunting yield following the $8.5bn Countrywide RMBS settlement, sources told GlobalCapital.
-
Corporate indebtedness in the US continues to be a focus for regulators, financiers and CLO investors, following the release of the 2016 Shared National Credit (SNC) review earlier this month.
-
Top tier US CLO managers maintained their hold on the market in the first six months of 2016, with the list of top managers holding steady year over year.
-
US CLO triple-A spreads are on a tear, with the latest offering tightening below the 150bp mark for the first time in 2016, buoyed by a broadening investor base and improved market sentiment.
-
Société Générale this week appointed a new European head of leveraged loan syndicate, after the former levloan boss left the bank.
-
The relatively low price of mezzanine CLO paper compared with other assets is driving a wave of interest from high yield corporate investors, market participants said this week.
